Press releases

You are here

Volume variants of Colli-Pee®

Novosanis launches volume variants of Colli-Pee® offering new applications in urine testing

We are excited to announce the launch of volume variants of Colli-Pee ® , our innovative urine-capturing device...
Fujirebio

Novosanis enters into distribution deal with Fujirebio

Novosanis announces deal with Fujirebio, a global leader in the field of in vitro diagnostics (IVD). Using our Colli-...
Orasure Technologies Inc

Novosanis acquired by OraSure Technologies Inc

Wijnegem, Belgium, January 8, 2019: Novosanis, a privately-held, Belgian company founded as a spinoff company from the...
European patent granted for Colli-Pee

European Patent granted for Colli-Pee

Novosanis announced today that the European Patent Office (EPO) has granted the company's patent application in Europe...
Colli-Pee approved by Mexican Health Authority

Colli-Pee approved by Mexican Health Authority

Wijnegem, Belgium, November 8, 2018: Novosanis, an innovative developer and producer of medical devices, announced...
Colli-Pee in Brazil

Novosanis obtains regulatory approval for Colli-Pee in Brazil

Wijnegem, Belgium, July 26 2018: Novosanis announced today that Colli-Pee a non-invasive self-sampling device suited...
Colli-Pee CE Certified

Colli-Pee with UCM preservative CE certified

Novosanis, an innovative developer and producer of medical devices, announced today that Colli-Pee, a self-sampling...
Henry Van de Velde Awards

Colli-Pee recognized at the prestigious Henry Van de Velde Awards

Novosanis and Voxdale have been awarded the prestigious Henry Van de Velde Award in Design for Healthcare.
Interreg CrossCare grant

Novosanis receives Interreg CrossCare grant for its Colli-Pee™ device

Interreg CrossCare grant allows Novosanis to build a next-generation Colli-Pee™ device
MdxHealth

Novosanis signs agreement with MDxHealth

Novosanis develops UrNCollect TM for SelectMDx for Prostate Cancer IVD kit of MDxHealth

First CE marked HPV test offering possibility to use first-void urine

Novosanis, a medical device company based in Wijnegem Belgium, together with GeneFirst, a molecular diagnostic company...
Mission to Japan

Novosanis participates in Belgian Royal Mission to Japan

Novosanis considers Japan as an important market due to its innovative vision towards healthcare and diagnostics.

Pages